|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online May 18, 2001 as doi:10.1096/fj.00-0862fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

2
* University of North Carolina Bowles Center for Alcohol Studies, and Department of Cell Biology and Anatomy, University of North Carolina School of Medicine, Chapel Hill North Carolina 27599, USA;
Neurology Service, VA Boston Healthcare System, West Roxbury, Massachusetts 02132; USA; and Department of Neurology, Harvard Medical School, Boston, and Department of Neurology, Brigham and Womens Hospital, Boston, Massachusetts 02115, USA
2Correspondence: Department of Neurology (127), Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132, USA. E-mail: mcharness{at}hms.harvard.edu
SPECIFIC AIMS
Alcohol may cause birth defects in part by disrupting the developmentally critical L1 cell adhesion molecule. Because 1-octanol antagonizes ethanol inhibition of L1-mediated cell adhesion, we used mouse whole embryo culture to test whether 1-octanol also prevents ethanol teratogenicity.
PRINCIPAL FINDINGS
1. Low concentrations of 1-octanol are not toxic in whole embryo
culture
To determine the toxicity of 1-octanol, gestational day 8 (GD8)
whole mouse embryos were cultured for 6 h in the absence and
presence of 1-octanol and transferred to control medium for an
additional 20 h. Somite pairs were counted after a total of
26 h in culture. Based on somite counts, treatment with 3 µM
1-octanol did not produce a delay in embryonic development, whereas 10
µM and higher concentrations of 1-octanol caused increasing
dysmorphogenesis (Fig. 1a
).
|
2. 1-Octanol decreases ethanol-induced dysmorphology
Embryos cultured for 6 h with 100 mM ethanol showed markedly
delayed in vitro development (13.2±0.6 somite pairs after 26 h,
n=23) compared with control embryos (19.1±0.4 somite pairs,
n=18, P<0.001) (Fig. 1b
, c
). The
toxicity of 100 mM ethanol was significantly reduced by coincubating
embryos with 3 µM 1-octanol (16.9±0.6 somite pairs; n=23,
P<0.001). Only 8.7% of the embryos treated with ethanol
alone had
17 somite pairs; in contrast, 94.4% of the control
embryos and 60.9% of the embryos treated with 1-octanol and ethanol
had
17 somite pairs. Conversely, whereas 43.5% of the embryos
treated with ethanol alone had
12 somite pairs, none of the control
embryos and only 4.3% of the embryos treated with ethanol plus
1-octanol were this small.
3. 1-Octanol decreases ethanol-induced apoptosis
To determine whether 1-octanol antagonizes ethanol-induced
apoptosis, GD8 mouse whole embryos were cultured for 6 h in the
absence and presence of alcohols and then an additional 6 h in
alcohol-free medium. Compared with controls, ethanol-exposed embryos
showed excessive Nile blue sulfate staining in the lateral margins of
the cranial neuroepithelium (Fig. 2b
, d
, f
), including the region of the neural crest.
TUNEL staining was also increased in the ethanol exposed embryos and
the distribution of TUNEL staining was similar to that obtained with
Nile blue sulfate (Fig. 2c
, e
, g
). Coincubation of embryos
with 3 µM 1-octanol greatly reduced the ethanol-induced increase in
Nile blue sulfate and TUNEL staining, indicating that 1-octanol
decreased ethanol-induced apoptosis.
|
4. L1 is expressed in GD8 mouse embryos
If 1-octanol antagonizes the early embryotoxicity of ethanol
through effects on L1, then L1 expression should be detectable in
GD89 whole mouse embryos. Anti L1 monoclonal antibody 745H7
(Covance; Richmond, CA) stained virtually all cell populations present
in histological sections through the head and neck of GD8 embryos. The
heaviest stained cells were localized to regions populated by
neural crest cells, a cell type that is particularly sensitive to
ethanol. Expression of predominantly the RSLE- negative isoform of L1
was confirmed by the polymerase chain reaction (PCR) and sequencing of
PCR products.
CONCLUSIONS
The brain abnormalities of children with alcohol-related birth defects, including fetal alcohol syndrome, can resemble those of children with L1 gene mutations. For this reason, we have speculated that inhibition of L1-mediated cellcell adhesion contributes to the teratogenic effects of ethanol. The major finding of these experiments is that 3 µM 1-octanol, a long-chain alcohol, significantly antagonizes the teratogenic effects of 100 mM ethanol, a short-chain alcohol, in mouse whole embryo culture. The same concentration of 1-octanol half-maximally antagonizes ethanol inhibition of L1-mediated cellcell adhesion. The structural similarity of these alcohols raises the possibility that 1-octanol decreases ethanol teratogenesis by blocking its interaction with L1.
Animal studies suggest that multiple actions of alcohol account for its teratogenicity, including induction of apoptosis. Our current study shows that 1-octanol greatly reduces ethanol-induced apoptosis, although the underlying mechanism is unclear. 1-Octanol could be an antagonist for multiple effects of ethanol on cell signaling; however, 1-octanol is a more potent agonist than ethanol in many of these signaling pathways. At this time, the only action for which 1-octanol is a demonstrated antagonist is ethanol inhibition of L1-mediated cellcell adhesion.
How might ethanol inhibition of cell adhesion lead to apoptosis?
Disruption of cellcell or cellsubstrate adhesion promotes apoptosis
through a reactive oxygen-dependent process known as anoikis. If
ethanol induces apoptosis by disrupting L1-mediated cell adhesion, then
1-octanol might prevent ethanol teratogenesis by blocking ethanols
interaction with L1 (Fig. 3
). L1 was detected in control mouse embryos as early as GD8, an early
stage of vulnerability to ethanol teratogenesis. The paradoxical
inhibition of ethanol teratogenicity by a longer chain 1-alcohol
suggests a strategy for developing compounds that prevent
alcohol-related birth defects.
|
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0862fje ; to cite this
article, use FASEB J. (May 18, 2001) 10.1096/fj.00-0862fje ![]()
This article has been cited by other articles:
![]() |
E. Arevalo, S. Shanmugasundararaj, M. F. Wilkemeyer, X. Dou, S. Chen, M. E. Charness, and K. W. Miller An alcohol binding site on the neural cell adhesion molecule L1 PNAS, January 8, 2008; 105(1): 371 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Goodlett, K. H. Horn, and F. C. Zhou Alcohol Teratogenesis: Mechanisms of Damage and Strategies for Intervention Experimental Biology and Medicine, June 1, 2005; 230(6): 394 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Wilkemeyer, S.-y. Chen, C. E. Menkari, K. K. Sulik, and M. E. Charness Ethanol Antagonist Peptides: Structural Specificity without Stereospecificity J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Wilkemeyer, S.-y. Chen, C. E. Menkari, D. E. Brenneman, K. K. Sulik, and M. E. Charness Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity PNAS, July 8, 2003; 100(14): 8543 - 8548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Wilkemeyer, C. E. Menkari, and M. E. Charness Novel Antagonists of Alcohol Inhibition of L1-Mediated Cell Adhesion: Multiple Mechanisms of Action Mol. Pharmacol., November 1, 2002; 62(5): 1053 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Wilkemeyer, C. E. Menkari, C. Y. Spong, and M. E. Charness Peptide Antagonists of Ethanol Inhibition of L1-Mediated Cell-Cell Adhesion J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |